Research ArticleArticle
Open Access
Prediction of Clinical Response After 1 Year of Infliximab Therapy in Rheumatoid Arthritis Based on Disease Activity at 3 Months: Posthoc Analysis of the RISING Study
Tsutomu Takeuchi, Nobuyuki Miyasaka, Takashi Inui, Toshiro Yano, Toru Yoshinari, Tohru Abe and Takao Koike
The Journal of Rheumatology April 2015, 42 (4) 599-607; DOI: https://doi.org/10.3899/jrheum.140572
Tsutomu Takeuchi
From the Division of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University; Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo; Mitsubishi Tanabe Pharma Corporation, Osaka; Saitama Medical Center, Saitama Medical University, Saitama; and the Sapporo Medical Center NTT EC, Hokkaido,
Japan.
Nobuyuki Miyasaka
Takashi Inui
Toshiro Yano
Toru Yoshinari
Tohru Abe
REFERENCES
- 1.↵
- Smolen JS,
- Landewé R,
- Breedveld FC,
- Buch M,
- Burmester G,
- Dougados M,
- et al.
- 2.↵
- Lipsky PE,
- van der Heijde DM,
- St Clair EW,
- Furst DE,
- Breedveld FC,
- Kalden JR,
- et al.
- 3.↵
- 4.↵
- 5.↵
- Westhovens R,
- Yocum D,
- Han J,
- Berman A,
- Strusberg I,
- Geusens P,
- et al.
- 6.↵
- Nam JL,
- Winthrop KL,
- van Vollenhoven RF,
- Pavelka K,
- Valesini G,
- Hensor EM,
- et al.
- 7.↵
- Yazici Y,
- Krasnokutsky S,
- Barnes JP,
- Hines PL,
- Wang J,
- Rosenblatt L
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- Dougados MR,
- van der Heijde DM,
- Brault Y,
- Koenig AS,
- Logeart IS
- 12.↵
- Takeuchi T,
- Miyasaka N,
- Tatsuki Y,
- Yano T,
- Yoshinari T,
- Abe T,
- et al.
- 13.↵
- Rahman MU,
- Strusberg I,
- Geusens P,
- Berman A,
- Yocum D,
- Baker D,
- et al.
- 14.↵
- St Clair EW,
- Wagner CL,
- Fasanmade AA,
- Wang B,
- Schaible T,
- Kavanaugh A,
- et al.
- 15.↵
- 16.↵
- Inoue E,
- Yamanaka H,
- Hara M,
- Tomatsu T,
- Kamatani N
- 17.↵
- 18.↵
- van Tuyl LH,
- Felson DT,
- Wells G,
- Smolen J,
- Zhang B,
- Boers M;
- American College of Rheumatology; European League against Rheumatism Committee to Define Remission for Clinical Trials
- 19.↵
- 20.↵
- Felson DT,
- Smolen JS,
- Wells G,
- Zhang B,
- van Tuyl LH,
- Funovitis J,
- et al.
- 21.↵
- Pavelka K,
- Jarosová K,
- Suchý D,
- Senolt L,
- Chroust K,
- Dusek L,
- et al.
- 22.↵
- 23.↵
- 24.↵
- Cohen SB,
- Emery P,
- Greenwald MW,
- Dougados M,
- Furie RA,
- Genovese MC,
- et al.
- 25.↵
- Smolen JS,
- Kay J,
- Doyle MK,
- Landewé R,
- Matteson EL,
- Wollenhaupt J,
- et al.
- 26.↵
- Smolen JS,
- Han C,
- Bala M,
- Maini RN,
- Kalden JR,
- van der Heijde D,
- et al.
- 27.↵
- Smolen JS,
- Han C,
- van der Heijde DM,
- Emery P,
- Bathon JM,
- Keystone E,
- et al;
- Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group
In this issue
The Journal of Rheumatology
Vol. 42, Issue 4
1 Apr 2015
Prediction of Clinical Response After 1 Year of Infliximab Therapy in Rheumatoid Arthritis Based on Disease Activity at 3 Months: Posthoc Analysis of the RISING Study
Tsutomu Takeuchi, Nobuyuki Miyasaka, Takashi Inui, Toshiro Yano, Toru Yoshinari, Tohru Abe, Takao Koike
The Journal of Rheumatology Apr 2015, 42 (4) 599-607; DOI: 10.3899/jrheum.140572
Prediction of Clinical Response After 1 Year of Infliximab Therapy in Rheumatoid Arthritis Based on Disease Activity at 3 Months: Posthoc Analysis of the RISING Study
Tsutomu Takeuchi, Nobuyuki Miyasaka, Takashi Inui, Toshiro Yano, Toru Yoshinari, Tohru Abe, Takao Koike
The Journal of Rheumatology Apr 2015, 42 (4) 599-607; DOI: 10.3899/jrheum.140572